Market Tracker

05/23 4:27pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.43
Delayed Data
As of 4:00pm ET
 +0.05 / +3.64%
Today’s Change
0.94
Today|||52-Week Range
6.25
-36.67%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.38
Today’s open1.35
Day’s range1.35 - 1.45
Volume344,107
Average volume (3 months)1,039,716
Market cap$77.1M
Dividend yield--
Data as of 4:00pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+14.73%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.37

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp-0.08-2.78%
AVEOAveo Pharmaceuticals...+0.02+2.28%
IMMYImprimis Pharmaceuti...-0.17-4.61%
ATNMActinium Pharmaceuti...+0.07+5.26%
Data as of 4:02pm ET, 05/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts